相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS
Yin M. Yang et al.
CELL STEM CELL (2013)
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2013)
Improving survival in a large French ALS center cohort
Paul H. Gordon et al.
JOURNAL OF NEUROLOGY (2012)
Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model
C. Sunyach et al.
NEUROPHARMACOLOGY (2012)
CHARACTERIZATION OF OXALIPLATIN-INDUCED CHRONIC PAINFUL PERIPHERAL NEUROPATHY IN THE RAT AND COMPARISON WITH THE NEUROPATHY INDUCED BY PACLITAXEL
W. H. Xiao et al.
NEUROSCIENCE (2012)
Emerging targets and treatments in amyotrophic lateral sclerosis
Lorne Zinman et al.
LANCET NEUROLOGY (2011)
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Merit Cudkowicz et al.
NATURE MEDICINE (2011)
How can we improve clinical trials in amyotrophic lateral sclerosis?
Paul H. Gordon et al.
NATURE REVIEWS NEUROLOGY (2011)
Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis
L. M. Duffy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Olesoxime prevents microtubule-targeting drug neurotoxicity: Selective preservation of EB comets in differentiated neuronal cells
Amandine Rovini et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The natural history of ALS is changing: Improved survival
Muddasir Qureshi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Olesoxime (cholest-4-en-3-one, oxime): Analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel
Wen Hua Xiao et al.
PAIN (2009)
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Specific Antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
ALS drug development: Reflections from the past and a way forward
Swati Aggarwal et al.
NEUROTHERAPEUTICS (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
V Meininger et al.
NEUROLOGY (2006)
Apoptosis in amyotrophic lateral sclerosis - what is the evidence?
S Sathasivam et al.
LANCET NEUROLOGY (2005)
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials
V Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
分享论文
